JP2005289953A - ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME - Google Patents
ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME Download PDFInfo
- Publication number
- JP2005289953A JP2005289953A JP2004134805A JP2004134805A JP2005289953A JP 2005289953 A JP2005289953 A JP 2005289953A JP 2004134805 A JP2004134805 A JP 2004134805A JP 2004134805 A JP2004134805 A JP 2004134805A JP 2005289953 A JP2005289953 A JP 2005289953A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial agent
- corynebacterium
- antibacterial
- methyl
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 239000004480 active ingredient Substances 0.000 title claims abstract description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 title abstract 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 title abstract 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 27
- 241000186216 Corynebacterium Species 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 230000014759 maintenance of location Effects 0.000 claims description 8
- 241000186245 Corynebacterium xerosis Species 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 26
- 241000894006 Bacteria Species 0.000 abstract description 9
- 241000186249 Corynebacterium sp. Species 0.000 abstract description 6
- 208000035985 Body Odor Diseases 0.000 abstract description 5
- 206010040904 Skin odour abnormal Diseases 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- -1 alkali metal salts Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 210000004243 sweat Anatomy 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000001166 anti-perspirative effect Effects 0.000 description 5
- 239000003213 antiperspirant Substances 0.000 description 5
- 239000002781 deodorant agent Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 244000005714 skin microbiome Species 0.000 description 4
- 239000003212 astringent agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OOOOFOPLSIWRAR-NTEUORMPSA-N 3,7,11-Trimethyl-6E,10-dodecadien-1-ol Chemical compound OCCC(C)CC\C=C(/C)CCC=C(C)C OOOOFOPLSIWRAR-NTEUORMPSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- CAQWNKXTMBFBGI-UHFFFAOYSA-N C.[Na] Chemical compound C.[Na] CAQWNKXTMBFBGI-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100030350 Prolactin-inducible protein Human genes 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- IMZFSONSIHHFAR-UHFFFAOYSA-L dichloroaluminum;hydrate Chemical compound O.Cl[Al]Cl IMZFSONSIHHFAR-UHFFFAOYSA-L 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000010178 pectin extract Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- CAYKLJBSARHIDI-UHFFFAOYSA-K trichloroalumane;hydrate Chemical compound O.Cl[Al](Cl)Cl CAYKLJBSARHIDI-UHFFFAOYSA-K 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、パラオキシ安息香酸メチルを有効成分とする抗菌剤、及び該抗菌剤を含有する外用組成物に関する。 The present invention relates to an antibacterial agent containing methyl paraoxybenzoate as an active ingredient and a composition for external use containing the antibacterial agent.
発汗に伴う不快臭は、本来は無臭かつ無菌である汗が皮表の微生物によって分解されることによって生じることが知られており、これに皮表や汗中のアンモニアが加わるとさらに特有の臭気となる。とりわけ体臭の中でも鼻をつくような独特な臭いである腋臭は、腋窩部のアポクリン汗腺から分泌されるアポクリン汗が皮表に存在するコリネバクテリウム属菌や表皮ブドウ球菌(これらの一定のバランスを保って皮膚に定着している細菌の集まりを、皮膚細菌叢と呼ぶ)によって分解されることで発生する(例えば非特許文献1参照)これらの皮膚細菌叢のうち、腋臭に直接関連する微生物は、コリネバクテリウム属菌であることが知られている。 The unpleasant odor associated with sweating is known to be caused by the decomposition of the odorless and sterile sweat by microorganisms on the skin surface. When ammonia in the skin surface or sweat is added to this, a more specific odor is generated. It becomes. In particular, the vomiting odor, which is a peculiar odor of body odor, has a certain balance between corynebacterium sp. And epidermis staphylococci that have apocrine sweat secreted from the apocrine sweat glands in the axilla. A group of bacteria that are kept and fixed on the skin is referred to as skin flora) (see, for example, Non-Patent Document 1) Among these skin flora, It is known to be a genus Corynebacterium.
従来、体臭の発生を抑制するために、発汗防止剤、制汗収斂剤、抗生物質または抗菌剤などが使用されている。しかしながら、発汗防止剤や制汗収斂剤は汗の分泌量の多い人には余り効果がなく、特にヒドロキシ塩化アルミニウム(アルミニウム塩化水和物)のようなアルミニウム塩からなる制汗収斂剤はそのタンパク質変性作用のため皮膚への刺激性が強いという問題がある。また、塩化ベンゼトニウムや塩化ベンザルコニウムなどの抗菌剤や抗生物質は、効果は高いものの、体臭の原因となる微生物だけでなく皮膚細菌叢を形成する微生物までも殺菌若しくは静菌してしまうため、健全な皮膚細菌叢形成による皮膚本来の自浄作用を損なってしまという危険性を有している。 Conventionally, antiperspirants, antiperspirant astringents, antibiotics or antibacterial agents have been used to suppress the generation of body odor. However, antiperspirants and antiperspirant astringents are not very effective for people with a high amount of sweat, especially antiperspirant astringents made of aluminum salts such as hydroxyaluminum chloride (aluminum chloride hydrate). There is a problem that it is highly irritating to the skin due to its degenerative action. In addition, although antibacterial agents and antibiotics such as benzethonium chloride and benzalkonium chloride are highly effective, not only microorganisms that cause body odor but also microorganisms that form skin flora will be sterilized or bacteriostatic, There is a risk that the skin's original self-cleaning action is impaired due to the formation of healthy skin flora.
そこで、不快な体臭を防止する方法を開発するためには、不快臭を発生する原因のもととなる菌に選択的な殺菌作用を有する抗菌剤を見出すことが必要とされている。
本発明は、腋臭の原因とされるコリネバクテリウム属菌に対して優れた抗菌作用を有する抗菌剤、及び該抗菌剤を含有する外用組成物を提供することを主な目的とする。 The main object of the present invention is to provide an antibacterial agent having an excellent antibacterial action against Corynebacterium which is a cause of a bad odor, and an external composition containing the antibacterial agent.
本発明者らは、従来、防腐剤として使用されていたパラオキシ安息香酸類のなかでも、特にパラオキシ安息香酸メチルが、コリネバクテリウム属菌に対して優れた抗菌作用を有することを見出し、本発明を完成するに至った。 The present inventors have found that among paraoxybenzoic acids conventionally used as preservatives, methyl paraoxybenzoate has an excellent antibacterial action against Corynebacterium, and the present invention It came to be completed.
本発明は、以下の抗菌剤及び外用組成物を提供する。
項1.パラオキシ安息香酸メチルを有効成分とするコリネバクテリウム属菌に対する抗菌剤。
項2.コリネバクテリウム属菌が、コリネバクテリウム キセロシス、コリネバクテリウム ミヌティシマム又はコリネバクテリウム テヌイスである項1に記載の抗菌剤。
項3.パラオキシ安息香酸メチルを0.2重量%以上含有する項1又は2のいずれかに記載の抗菌剤。
項4.さらに皮膚滞留剤を含有する項1〜3のいずれかに記載の抗菌剤。
項5.該皮膚滞留剤が、プロピレングリコールである項4に記載の抗菌剤。
項6.項1〜5のいずれかに記載の抗菌剤を含有する外用組成物。
項7.腋臭防止用である項6に記載の外用組成物。The present invention provides the following antibacterial agents and compositions for external use.
Item 1. An antibacterial agent against Corynebacterium which contains methyl paraoxybenzoate as an active ingredient.
Item 2. Item 2. The antibacterial agent according to item 1, wherein the Corynebacterium is Corynebacterium xerosis, Corynebacterium minutishima or Corynebacterium tenuis.
Item 3. Item 3. The antibacterial agent according to any one of Items 1 and 2, which contains 0.2% by weight or more of methyl paraoxybenzoate.
Item 4. Item 4. The antibacterial agent according to any one of Items 1 to 3, further comprising a skin retention agent.
Item 5. Item 5. The antibacterial agent according to Item 4, wherein the skin retention agent is propylene glycol.
Item 6. Item 6. An external composition containing the antibacterial agent according to any one of Items 1 to 5.
Item 7. Item 7. The composition for external use according to Item 6, which is used for preventing odor.
本発明の抗菌剤の有効成分であるパラオキシ安息香酸メチルは、医薬品、医薬部外品、化粧品及び食品の分野で使用されているものを広く使用することができる。パラオキシ安息香酸メチルとしては、塩の形態であってもよく、かかる塩としてはパラオキシ安息香酸メチルナトリウム等のアルカリ金属塩を例示することができる。パラオキシ安息香酸メチルまたはその塩は、1種単独で使用してもまた2種以上を任意に組み合わせて使用することもできる。 As the methyl paraoxybenzoate which is an active ingredient of the antibacterial agent of the present invention, those used in the fields of pharmaceuticals, quasi drugs, cosmetics and foods can be widely used. The methyl paraoxybenzoate may be in the form of a salt, and examples of such a salt include alkali metal salts such as methyl sodium paraoxybenzoate. Methyl paraoxybenzoate or a salt thereof can be used alone or in any combination of two or more.
実施例に示すように、本発明の抗菌剤は、コリネバクテリウム属菌(Corynebacterium sp.)に対して優れた抗菌効果を有することを特徴とする。ここでコリネバクテリウム属菌(Corynebacterium sp.)としては、この属の範疇にあるグラム陽性桿菌であれば特に制限されないが、好ましくは腋臭発生の原因となる菌(以下、本発明において腋臭菌ともいう。)であり、このような腋臭菌としては例えば、コリネバクテリウム ミヌティシマム(Corynebacterium minutissimum)、コリネバクテリウム キセロシス(Corynebacterium xerosis)、又はコリネバクテリウム テヌイス(Corynebacterium tenuis)等が知られている。 As shown in the Examples, the antibacterial agent of the present invention is characterized by having an excellent antibacterial effect against Corynebacterium sp. Here, Corynebacterium sp. Is not particularly limited as long as it is a gram-positive gonococcus in the category of this genus, but is preferably a bacterium that causes generation of odor (hereinafter referred to as odor bacterium in the present invention). Examples of such malodorous bacteria include Corynebacterium minutisium, Corynebacterium xerosis, Corynebacterium tenuis, and the like.
パラオキシ安息香酸メチルを有効成分とする抗菌剤を調製した場合、コリネバクテリウム属菌に対する殺菌作用は、パラオキシ安息香酸メチルの有効量として、0.1重量%程度を越える量、好ましくは0.15重量%程度以上、より好ましくは0.2重量%程度以上である。 When an antibacterial agent containing methyl paraoxybenzoate as an active ingredient is prepared, the bactericidal action against the genus Corynebacterium is an amount exceeding about 0.1% by weight, preferably 0.15, as an effective amount of methyl paraoxybenzoate. It is about wt% or more, more preferably about 0.2 wt% or more.
上記のパラオキシ安息香酸メチルを有効成分とする抗菌剤に、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール等の低揮発性及び低皮膚浸透性の皮膚滞留剤を配合することができる。本発明の抗菌剤と併用する場合、該皮膚滞留剤としては、特にプロピレングリコールが好ましい。これらの皮膚滞留剤を併用することによって、本発明の抗菌剤を皮膚上に滞留させることができ、長時間にわたって抗菌効果を得ることができる。 A low volatility and low skin permeability skin retention agent such as propylene glycol, dipropylene glycol, 1,3-butylene glycol can be blended with the antibacterial agent containing methyl paraoxybenzoate as an active ingredient. When used in combination with the antibacterial agent of the present invention, propylene glycol is particularly preferable as the skin retention agent. By using these skin retention agents in combination, the antibacterial agent of the present invention can be retained on the skin, and an antibacterial effect can be obtained for a long time.
該抗菌剤中の皮膚滞留剤の配合量としては、抗菌作用を発揮するのに充分な時間滞留が可能であり、本発明の効果を妨げない量であれば特に制限されないが、通常、1〜50重量%程度、好ましくは5〜40重量%程度、より好ましくは10〜30重量%程度である。 The blending amount of the skin retention agent in the antibacterial agent is not particularly limited as long as it can be retained for a time sufficient to exert an antibacterial action and does not interfere with the effects of the present invention. About 50% by weight, preferably about 5-40% by weight, more preferably about 10-30% by weight.
さらに、本発明の抗菌剤は、本発明の効果を妨げないことを限度としてパラオキシ安息香酸メチル以外の成分として他の抗菌成分を含有することもできる。かかる抗菌成分としては、具体的にはトリクロサン、トリクロロカルバニリド、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩酸クロルヘキシジン、ジヒドロファルネソール、イソプロピルメチルフェノール、チモール、ヒノキチオール、塩化セチルピリジニウム、エタノール、イソプロパノール等を例示することができる。本発明抗菌剤にこれらの抗菌成分を含有させた場合、パラオキシ安息香酸メチルは、上記した有効量よりも少ない量で抗菌作用を発揮することが期待できる。したがって、本発明の抗菌剤におけるパラオキシ安息香酸メチルの有効量は、前述する範囲(0.1重量%を超える量)に限定されない。 Furthermore, the antibacterial agent of the present invention can contain other antibacterial components as components other than methyl paraoxybenzoate as long as the effects of the present invention are not hindered. Specific examples of such antibacterial components include triclosan, trichlorocarbanilide, benzalkonium chloride, benzethonium chloride, halocarban, chlorhexidine hydrochloride, dihydrofarnesol, isopropylmethylphenol, thymol, hinokitiol, cetylpyridinium chloride, ethanol, isopropanol, etc. Can be illustrated. When these antibacterial components are contained in the antibacterial agent of the present invention, methyl paraoxybenzoate can be expected to exhibit an antibacterial action in an amount smaller than the above-mentioned effective amount. Therefore, the effective amount of methyl paraoxybenzoate in the antibacterial agent of the present invention is not limited to the above-described range (amount exceeding 0.1% by weight).
本発明の抗菌剤は、皮膚に存在するコリネバクテリウム属菌(Corynebacterium sp.)に対して抗菌作用を有することから、抗菌成分として外用組成物に配合して用いることができる。特に本発明の抗菌剤は、腋臭菌に対して優れた殺菌作用を発揮することから腋臭防止のための外用組成物の抗菌成分として用いることができる。この場合、本発明の抗菌剤の外用組成物への配合割合としては、有効成分であるパラオキシ安息香酸メチルがコリネバクテリウム属菌に対して抗菌効果を発揮する量であればよく、この範囲において特に制限されないが、具体的には該外用組成物中にパラオキシ安息香酸メチルの含有量として0.1重量程度%を超える量、好ましくは0.15重量%程度以上より好ましくは0.2重量%程度以上の範囲で含まれることが望ましい。 Since the antibacterial agent of the present invention has an antibacterial action against Corynebacterium sp. Existing in the skin, it can be used as an antibacterial component in an external composition. In particular, the antibacterial agent of the present invention can be used as an antibacterial component of a composition for external use for preventing a bad smell because it exhibits an excellent bactericidal action against bad smell bacteria. In this case, the proportion of the antibacterial agent of the present invention to the composition for external use may be an amount in which the active ingredient methyl paraoxybenzoate exhibits an antibacterial effect against Corynebacterium, and in this range Although not particularly limited, specifically, the amount of methyl paraoxybenzoate in the external composition exceeds about 0.1% by weight, preferably about 0.15% by weight or more, more preferably 0.2% by weight. It is desirable that it be included within a range of more than about.
本発明は、かくして調製される外用組成物をも提供するものである。該外用組成物は、腋臭を防止する目的で、医薬品、医薬部外品及び化粧料(香粧料)の分野において広く用いることができる。その形態も特に制限されることなくクリーム、軟膏、ローション、スプレー、エアゾール、乳液、フォーム、洗浄料、石鹸、浴用剤、スキンコンディショナー、化粧水、パック剤、ファンデーション並びに上記抗菌剤をシート状基材に含浸させたシート剤、貼付剤またはパップ剤、ロールオン剤等の使用形態に合わせて液状、半固形状、気泡状及び固形状に適宜調製される。 The present invention also provides a composition for external use thus prepared. The composition for external use can be widely used in the fields of pharmaceuticals, quasi-drugs, and cosmetics (cosmetics) for the purpose of preventing odor. The form is not particularly limited, and cream, ointment, lotion, spray, aerosol, emulsion, foam, cleaning agent, soap, bath preparation, skin conditioner, lotion, pack agent, foundation and the above antibacterial agent are formed into a sheet-like base material. According to usage forms such as a sheet agent, a patch or a poultice, a roll-on agent, etc. impregnated into a liquid, it is appropriately prepared in a liquid, semi-solid, bubble and solid form.
該外用組成物は、パラオキシ安息香酸メチルを有効成分とする上記抗菌剤に加えて、各種形態に応じて、一般的に外用組成物に配合される担体;防腐剤、保存剤、安定剤、沈殿防止剤、pH調整剤、香料、界面活性剤(アニオン性、カチオン性、ノニオン性、両性界面活性剤)、着色剤、清澄剤、粘度調整剤、殺菌抗菌剤、精油等の各種添加剤を配合することができる。かかる担体並びに添加剤としては、人体に安全なものが好ましく、より好ましくは皮膚等に対して刺激性のないものである。 In addition to the above-mentioned antibacterial agent containing methyl paraoxybenzoate as an active ingredient, the composition for external use generally comprises a carrier generally incorporated in the composition for external use according to various forms; an antiseptic, a preservative, a stabilizer, a precipitate Contains various additives such as inhibitors, pH adjusters, fragrances, surfactants (anionic, cationic, nonionic, amphoteric surfactants), colorants, refining agents, viscosity modifiers, bactericidal antibacterial agents, and essential oils. can do. Such carriers and additives are preferably those that are safe for the human body, and more preferably those that are not irritating to the skin or the like.
担体としては、例えば液状形態の場合は、水(例えばイオン交換水)、アルコール(例えばエタノール)、並びに水溶性溶剤(例えばプロピレングリコールやグリセリン等)などを、また固体形態の場合は各種のゲル化剤(例えば、カラギーナンやアルギン酸ナトリウム等の海藻多糖類;グアーガムやタマリンドシードガム等の種子多糖類;アラビアガムやトラガントガムなどの植物樹液多糖類;キサンタンガムやジェランガム等の発酵多糖類;ゼラチン等の蛋白質;カルボキシメチルセルロース等のセルロース誘導体等);タルクやシリカ等の無機材;ポリアクリル酸ナトリウム等のポリアクリル酸類などをあげることができる。 Examples of the carrier include water (for example, ion-exchanged water), alcohol (for example, ethanol), and a water-soluble solvent (for example, propylene glycol and glycerin) in the case of a liquid form, and various gellings in the case of a solid form. Agents (for example, seaweed polysaccharides such as carrageenan and sodium alginate; seed polysaccharides such as guar gum and tamarind seed gum; plant sap polysaccharides such as gum arabic and tragacanth gum; fermentation polysaccharides such as xanthan gum and gellan gum; proteins such as gelatin; And cellulose derivatives such as carboxymethyl cellulose); inorganic materials such as talc and silica; and polyacrylic acids such as sodium polyacrylate.
防腐剤としては、安息香酸、ソルビン酸、プロピオン酸、デヒドロ酢酸、サリチル酸、エデト酸及びそれら塩;亜硫酸ナトリウム、次亜硫酸ナトリウム、ピロ亜硫酸ナトリウム等の無機塩類;ペクチン抽出物などの植物由来成分などを例示することができる。 Examples of preservatives include benzoic acid, sorbic acid, propionic acid, dehydroacetic acid, salicylic acid, edetic acid and their salts; inorganic salts such as sodium sulfite, sodium hyposulfite and sodium pyrosulfite; plant-derived components such as pectin extract It can be illustrated.
沈殿防止剤としては、二酸化ケイ素、ステアリン酸マグネシウム等の微粒子粉体、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタンモノステアレート等の界面活性剤及びキサンタンガム、ポリエチレングリコール等のゲル化剤等を例示することができる。 Examples of suspending agents include fine particle powders such as silicon dioxide and magnesium stearate, surfactants such as polyoxyethylene hydrogenated castor oil and polyoxyethylene sorbitan monostearate, and gelling agents such as xanthan gum and polyethylene glycol. can do.
pH調整剤としては、クエン酸、フマル酸、DL−リンゴ酸並びにその塩類;炭酸水素ナトリウム、炭酸カリウムなどの炭酸塩類;リン酸、リン酸二水素ナトリウム等のリン酸塩などを例示することができる。 Examples of the pH adjuster include citric acid, fumaric acid, DL-malic acid and salts thereof; carbonates such as sodium hydrogen carbonate and potassium carbonate; phosphates such as phosphoric acid and sodium dihydrogen phosphate; it can.
前述する各種の成分は単に一例を記載したに過ぎず、本発明はこれらの成分に何ら限定されることはない。すなわち本発明の皮膚外用剤には、他の添加成分も含めて、通常外用剤の成分として使用される各種の成分が使用できる。 The various components described above are merely examples, and the present invention is not limited to these components. That is, in the external preparation for skin of the present invention, various components that are usually used as components for external preparations can be used, including other additive components.
本発明の外用組成物、特に腋臭防止用の外用組成物は、コリネバクテリウム属菌、特に腋臭の発生の原因となる腋臭菌に対する殺菌作用に基づいて、腋臭や汗臭の発生を防止する効果に優れている。従って、該外用組成物は、別の観点から腋臭や汗臭の発生を抑制するために使用される防臭剤(防体臭剤)、特に防腋臭剤として位置づけることもできる。 The composition for external use of the present invention, especially the composition for external use for preventing odor, is an effect of preventing the generation of odor and sweat odor based on the bactericidal action against Corynebacterium, particularly the odor bacterium causing the generation of odor. Is excellent. Therefore, the composition for external use can be positioned as a deodorant (anti-body odorant) used for suppressing the generation of a foul odor or sweat odor from another viewpoint, particularly as a deodorant.
さらに本発明の外用組成物は、コリネバクテリウム属菌が存在する皮膚(皮表)に直接塗布する使用態様のほか、スプレーやエアゾールなどの形態や洗濯仕上げ剤やコーティング剤などの形態に調製することによってコリネバクテリウム属菌が付着した(または付着する可能性のある)下着やシャツ等の衣類に噴霧、浸漬またはコーティングする使用態様で用いることができる。 Furthermore, the composition for external use of the present invention is prepared in a form such as a spray or aerosol, a laundry finish or a coating agent in addition to a use form directly applied to the skin (skin surface) where Corynebacterium is present. Thus, it can be used in a use mode in which spraying, dipping or coating is applied to clothing such as underwear or shirt to which Corynebacterium is attached (or possibly attached).
また本発明の防臭剤(防体臭剤、防腋臭剤)には、本発明の効果を妨げないことを限度として、上記その他の抗菌成分に加えて、衣類用のスプレー剤やエアゾール剤等に配合される公知の防腐剤、保存剤、安定剤、沈殿防止剤、pH調整剤、香料、界面活性剤(アニオン性、カチオン性、ノニオン性、両性界面活性剤)、清澄剤、粘度調整剤、殺菌抗菌剤等の各種添加剤を配合することができる。かかる担体並びに添加剤としては、人体に安全なものが好ましく、より好ましくは皮膚等に対して刺激性のないものである。 In addition to the above-mentioned other antibacterial components, the deodorant of the present invention (anti-body deodorant, anti-deodorant) is blended in clothing sprays, aerosols, etc. in addition to the above antibacterial components. Known preservatives, preservatives, stabilizers, precipitation inhibitors, pH adjusters, fragrances, surfactants (anionic, cationic, nonionic, amphoteric surfactants), clarifiers, viscosity modifiers, bactericides Various additives such as antibacterial agents can be blended. Such carriers and additives are preferably those that are safe for the human body, and more preferably those that are not irritating to the skin or the like.
本発明によれば、コリネバクテリウム属菌に対して優れた抗菌作用を有する抗菌剤、及び該抗菌剤を含有する外用組成物を提供することができる。さらに、該抗菌剤に低揮発性、低皮膚浸透性であるプロピレングリコールを配合することにより、長く皮膚上に滞留させることで、長時間にわたって抗菌効果を発揮できる抗菌剤及び該抗菌剤を含有する外用組成物を提供することができる。 According to the present invention, it is possible to provide an antibacterial agent having an excellent antibacterial action against Corynebacterium, and an external composition containing the antibacterial agent. Furthermore, by containing propylene glycol having low volatility and low skin permeability in the antibacterial agent, the antibacterial agent capable of exerting an antibacterial effect for a long time by containing on the skin for a long time and the antibacterial agent are contained. An external composition can be provided.
以下、実施例及び処方例をあげて本発明を具体的に説明するが、本発明はこれらの実施例に何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example and a formulation example are given and this invention is demonstrated concretely, this invention is not limited to these Examples at all.
試験方法
ペーパーディスク法による阻止円径の測定により抗菌力を評価した。 Test method Antibacterial activity was evaluated by measuring the inhibition circle diameter by the paper disk method.
コリネバクテリウム ミヌティシマムを、トリプチケースソイ寒天培地に塗布し、35℃にて24時間、増菌させた後、減菌生理食塩水にMacfaland0.5になるように懸濁させた。 Corynebacterium minutishimam was applied to trypticase soy agar medium, and the cells were enriched at 35 ° C. for 24 hours, and then suspended in sterilized physiological saline to have Macfarand 0.5.
シャーレ中のトリプチケースソイ寒天培地上に、この懸濁液50μLをコンラージ棒で均一に塗布し、その上にペーパーディスク(直径8mm)を置いて試料(パラオキシ安息香酸メチル、パラオキシ安息香酸エチル又はパラオキシ安息香酸プロピル)50μLを含浸させた。これを35℃にて24時間培養後、阻止円の有無とその直径を測定した。 Apply 50 μL of this suspension uniformly on a trypticase soy agar medium in a petri dish with a conical rod, and place a paper disk (diameter 8 mm) on the sample (methyl paraoxybenzoate, ethyl paraoxybenzoate or 50 μL of propyl paraoxybenzoate) was impregnated. After incubation at 35 ° C. for 24 hours, the presence or absence of a blocking circle and its diameter were measured.
試験結果
0.2重量%のパラオキシ安息香酸メチルでは、阻止円形成が見られたが、それ以外の濃度では阻止円形成は見られなかった。また、パラオキシ安息香酸エチル及びパラオキシ安息香酸プロピルにおいては、0.01重量%、0.1重量%又は0.2重量%のいずれの濃度においても阻止円形成は見られなかった。 Test results In 0.2% by weight of methyl paraoxybenzoate, inhibition circle formation was observed, but no inhibition circle formation was observed at other concentrations. Further, in the case of ethyl paraoxybenzoate and propyl paraoxybenzoate, no inhibition circle formation was observed at any concentration of 0.01% by weight, 0.1% by weight or 0.2% by weight.
従って、0.2重量%のパラオキシ安息香酸メチルにコリネバクテリウム ミヌティシマムに対して抗菌作用があることがわかった。 Therefore, it was found that 0.2% by weight of methyl paraoxybenzoate has an antibacterial action against Corynebacterium minutisimam.
パラオキシ安息香酸メチル、パラオキシ安息香酸エチル又はパラオキシ安息香酸プロピルを0.01重量%、0.1重量%又は0.2重量%用いた場合、及びプロピレングリコールを5重量%、10重量%又は20重量%用いた場合のペーパーディスク法による測定結果を表1に示す。 When 0.01%, 0.1%, or 0.2% by weight of methyl paraoxybenzoate, ethyl paraoxybenzoate, or propyl paraoxybenzoate is used, and 5% by weight, 10% by weight, or 20% by weight of propylene glycol Table 1 shows the results of measurement by the paper disk method when% is used.
以下、パラオキシ安息香酸メチルを用いた製剤の処方例を示すが、本発明はこれに限定されるものではない。 Hereinafter, although the formulation example of the formulation using methyl paraoxybenzoate is shown, this invention is not limited to this.
[処方例1]
[g]
軟膏 パラオキシ安息香酸メチル 0.2
グリチルリチン酸ジカリウム 0.5
ベントナイト 25
カオリン 25
グリセリン 15
プロピレングリコール 10
精製水 24.3
合計 100[Prescription Example 1]
[G]
Ointment Methyl paraoxybenzoate 0.2
Dipotassium glycyrrhizinate 0.5
Bentonite 25
Kaolin 25
Glycerin 15
Propylene glycol 10
Purified water 24.3
Total 100
[処方例2]
液剤 [g]
ポリオキシエチレンオレイルエーテル1
エタノール 10
パラオキシ安息香酸メチル 0.2
精製水 88.8
合計 100[Prescription Example 2]
Liquid [g]
Polyoxyethylene oleyl ether 1
Ethanol 10
Methyl paraoxybenzoate 0.2
Purified water 88.8
Total 100
[処方例3]
エアゾール [g]
プロピレングリコール 20
パラオキシ安息香酸メチル 0.2
イソプロピルメチルフェーノール0.1
精製水 24.9
液化石油ガス 50
合計 100[Prescription Example 3]
Aerosol [g]
Propylene glycol 20
Methyl paraoxybenzoate 0.2
Isopropyl methylphenol 0.1
Purified water 24.9
Liquefied petroleum gas 50
Total 100
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134805A JP2005289953A (en) | 2004-03-31 | 2004-03-31 | ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME |
PCT/JP2004/013899 WO2005099683A1 (en) | 2004-03-31 | 2004-09-24 | Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134805A JP2005289953A (en) | 2004-03-31 | 2004-03-31 | ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005289953A true JP2005289953A (en) | 2005-10-20 |
Family
ID=35149751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004134805A Pending JP2005289953A (en) | 2004-03-31 | 2004-03-31 | ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2005289953A (en) |
WO (1) | WO2005099683A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255711A (en) * | 2001-02-28 | 2002-09-11 | Kobayashi Pharmaceut Co Ltd | Antibacterial composition |
JP2002325828A (en) * | 2001-05-02 | 2002-11-12 | Ikeda Shokken Kk | Deodorant and use thereof |
JP2003321347A (en) * | 2002-05-07 | 2003-11-11 | Rohto Pharmaceut Co Ltd | Gel ointment |
JP2003335704A (en) * | 2002-05-17 | 2003-11-28 | Xantech Pharmaceuticals Inc | Composite composition of antisudorific and antibacterial agent |
JP2005239705A (en) * | 2004-02-27 | 2005-09-08 | Stiefel Lab Inc | Local antibacterial preparation |
-
2004
- 2004-03-31 JP JP2004134805A patent/JP2005289953A/en active Pending
- 2004-09-24 WO PCT/JP2004/013899 patent/WO2005099683A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255711A (en) * | 2001-02-28 | 2002-09-11 | Kobayashi Pharmaceut Co Ltd | Antibacterial composition |
JP2002325828A (en) * | 2001-05-02 | 2002-11-12 | Ikeda Shokken Kk | Deodorant and use thereof |
JP2003321347A (en) * | 2002-05-07 | 2003-11-11 | Rohto Pharmaceut Co Ltd | Gel ointment |
JP2003335704A (en) * | 2002-05-17 | 2003-11-28 | Xantech Pharmaceuticals Inc | Composite composition of antisudorific and antibacterial agent |
JP2005239705A (en) * | 2004-02-27 | 2005-09-08 | Stiefel Lab Inc | Local antibacterial preparation |
Non-Patent Citations (1)
Title |
---|
桝渕 幸吉, 最近の皮膚外用剤, vol. 第1版, JPN6010040912, 1991, pages 160 - 166, ISSN: 0001679305 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005099683A1 (en) | 2005-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1202243A (en) | Deodorant compound | |
JP3529093B2 (en) | Combinations of compounds with bactericidal activity | |
JP2008110999A (en) | Antibacterial composition and deodorant agent | |
US20030215472A1 (en) | Methods and compositions employing a dialkyl amide | |
JPH0892011A (en) | Deodorizing make-up goods | |
PT87807B (en) | PROCESS FOR THE PREPARATION OF DEODORIZING AND ANTIMICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPIC FORMULATIONS | |
JPH0753344A (en) | Deodorizing activity compound combinated substance based on alpha. and omega. - alkanedicarboxylic acid and wool wax acid | |
JPH0826957A (en) | Compounding agent of deodorizing active compound based on alpha, omega-alkane dicarboxylic acid and oligoglycerol monocarboxylate ester | |
JPWO2015146398A1 (en) | Deodorant composition and deodorant agent | |
JPS61243010A (en) | Cosmetic containing epsilon-polylysine and hydrochloride thereof as preservative and germicide incorporated therein | |
JP4565275B2 (en) | Antibacterial composition | |
JP6474963B2 (en) | Cleaning composition | |
JP4666938B2 (en) | Plant antibacterial composition | |
CA2318932C (en) | Deodorant composition containing d-amino acid | |
JP4743704B2 (en) | Antibacterial agent for bad odor bacteria, anti-odor agent and external preparation for skin containing the antibacterial agent | |
JP2007145771A (en) | Antibacterial agent composition and deodorant agent | |
EP2872220B1 (en) | Deodorant methods | |
JP2018521099A (en) | Cosmetic formulations that reduce sweat | |
JP2005289953A (en) | ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME | |
JP2019081763A (en) | Cleaning composition | |
JP5025535B2 (en) | Antibacterial agent composition and deodorant composition | |
BR112017013208B1 (en) | use of octenidine dihydrochloride | |
JP5586130B2 (en) | Antibacterial composition and cosmetics | |
JP2006096719A (en) | Deodorizing composition and deodorant preparation | |
JP5393962B2 (en) | Antibacterial agent for odor-causing bacteria and anti-odor agent containing the antibacterial agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100728 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101207 |